Licensing and Partnerships

Licensing
Leveraging one of the most comprehensive molecular and pharmacogenomics services infrastructures in the industry, PGxHealth is ideally positioned to introduce novel pharmacogenomic assays to the clinical marketplace through its two CLIA laboratories and its team of seasoned professionals.

With a rich history of in-licensing, validation and commercialization of early stage markers, PGxHealth is actively seeking novel genetic markers from academia, biotech, pharmaceutical and discovery companies to in-license or partner for development. In addition, the company has continued to grow its visibility directly or through partnerships with providers in CNS and Cardiovascular, setting the stage for the introduction of a growing number novel genetic tests.

Partnerships
PGxHealth’s success in pharmacogenomic partnering, spanning the biotech, pharmaceutical and diagnostic sectors, the Company and its affiliates know the value such relationships can bring to both parties.  

In order to build partnerships that are truly strategic assets for both, PGxHealth believes in forging relationships that;

• are flexible and creative
• have a common set of expectations and vision
• meet the needs of each partner

To inquire about partnerships with PGxHealth, please click our email link busdev@pgxhealth.com.